It isn't all about size and near-term EPS accretion, said Deutsche Bank analyst Gregg Gilbert, speaking in regard to Teva ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE